These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
389 related items for PubMed ID: 8147907
1. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Chen G, Waxman DJ. Biochem Pharmacol; 1994 Mar 15; 47(6):1079-87. PubMed ID: 8147907 [Abstract] [Full Text] [Related]
2. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells. Chen G, Waxman DJ. Biochem Pharmacol; 1995 May 26; 49(11):1691-701. PubMed ID: 7786310 [Abstract] [Full Text] [Related]
3. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Xu BH, Gupta V, Singh SV. Arch Biochem Biophys; 1994 Jan 26; 308(1):164-70. PubMed ID: 8311448 [Abstract] [Full Text] [Related]
4. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067. Xu BH, Singh SV. Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311 [Abstract] [Full Text] [Related]
5. Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers. Ford JM, Hait WN, Matlin SA, Benz CC. Cancer Lett; 1991 Jan 01; 56(1):85-94. PubMed ID: 2004358 [Abstract] [Full Text] [Related]
6. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines. Peters RH, Jollow DJ, Stuart RK. Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933 [Abstract] [Full Text] [Related]
7. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC. Biochem Pharmacol; 1987 Jan 01; 36(1):147-53. PubMed ID: 3801051 [Abstract] [Full Text] [Related]
8. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Wang YY, Teicher BA, Shea TC, Holden SA, Rosbe KW, al-Achi A, Henner WD. Cancer Res; 1989 Nov 15; 49(22):6185-92. PubMed ID: 2804968 [Abstract] [Full Text] [Related]
9. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity. Alaoui-Jamali MA, Panasci L, Centurioni GM, Schecter R, Lehnert S, Batist G. Cancer Chemother Pharmacol; 1992 Nov 15; 30(5):341-7. PubMed ID: 1505071 [Abstract] [Full Text] [Related]
10. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Mistry P, Loh SY, Kelland LR, Harrap KR. Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583 [Abstract] [Full Text] [Related]
11. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells. Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E. Mol Pharmacol; 1996 Jun 11; 49(6):1012-20. PubMed ID: 8649339 [Abstract] [Full Text] [Related]
12. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR. Br J Cancer; 1991 Aug 11; 64(2):215-20. PubMed ID: 1892748 [Abstract] [Full Text] [Related]
13. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. Evans CG, Bodell WJ, Tokuda K, Doane-Setzer P, Smith MT. Cancer Res; 1987 May 15; 47(10):2525-30. PubMed ID: 2882834 [Abstract] [Full Text] [Related]
14. Role of glutathione and glutathione S-transferase in chlorambucil resistance. Yang WZ, Begleiter A, Johnston JB, Israels LG, Mowat MR. Mol Pharmacol; 1992 Apr 15; 41(4):625-30. PubMed ID: 1569917 [Abstract] [Full Text] [Related]
15. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells. Benathan M, Alvero-Jackson H, Mooy AM, Scaletta C, Frenk E. Melanoma Res; 1992 Dec 15; 2(5-6):305-14. PubMed ID: 1337997 [Abstract] [Full Text] [Related]
16. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation. Shrieve DC, Harris JW. Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1171-4. PubMed ID: 3744936 [Abstract] [Full Text] [Related]
17. Selective and synergistic activity of L-S,R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase. Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC. Pigment Cell Res; 1997 Aug 15; 10(4):236-49. PubMed ID: 9263331 [Abstract] [Full Text] [Related]
18. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis. Yokomizo A, Kohno K, Wada M, Ono M, Morrow CS, Cowan KH, Kuwano M. J Biol Chem; 1995 Aug 18; 270(33):19451-7. PubMed ID: 7642628 [Abstract] [Full Text] [Related]
19. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Kramer RA, Greene K, Ahmad S, Vistica DT. Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359 [Abstract] [Full Text] [Related]
20. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Russo A, DeGraff W, Friedman N, Mitchell JB. Cancer Res; 1986 Jun 15; 46(6):2845-8. PubMed ID: 2421885 [Abstract] [Full Text] [Related] Page: [Next] [New Search]